Table 1.
Baseline Clinicopathological Features in 109 Gastric Cancer Patients.
| Characteristics | No. of patients (%) | Characteristics | No. of patients (%) |
|---|---|---|---|
| Age group | Lymph node status | ||
| <30 | 1 (0.9) | Negative | 40 (36.7) |
| 30-39 | 11 (10.1) | 1-2 positive node(s) | 42 (38.5) |
| 40-49 | 12 (11.0) | 3-6 positive nodes | 17 (15.6) |
| 50-59 | 40 (36.7) | 7-15 positive nodes | 9 (8.3) |
| ≥60 | 45 (41.3) | > 15 positive nodes | 1 (0.9) |
| Sex | LVI | ||
| Male | 68 (62.4) | Present | 42 (38.5) |
| Female | 41 (37.6) | Perineural invasion | |
| Present | 41 (37.6) | ||
| Tumor location | Invasive depth | ||
| Antrum | 87 (79.8) | T1 | 1 (0.9) |
| Antrum—Lesser curvature | 7 (6.4) | T2 | 18 (16.5) |
| Fundus/Corpus | 5 (4.6) | T3 | 16 (14.7) |
| Corpus—Lesser curvature | 3 (2.8) | T4a | 50 (45.9) |
| Cardia | 3 (2.8) | T4b | 24 (22.0) |
| Pyloric Antrum | 3 (2.8) | ||
| Unknown | 1 (0.9) | ||
| Histopathological type | pTNM Stage | ||
| Adenocarcinoma, NOS | 86 (78.9) | I | 3 (2.8) |
| Signet ring cell | 16 (14.7) | IIA | 24 (22.0) |
| Mucinous | 7 (6.4) | IIB | 24 (22.0) |
| IIIA | 21 (19.3) | ||
| IIIB | 26 (23.9) | ||
| IIIC | 11 (10.1) | ||
| Differentiated grade | Tumor budding | ||
| Well-differentiated | 7 (8.1) | Grade I | 25 (22.9) |
| Moderately-differentiated | 36 (41.9) | Grade II | 34 (31.2) |
| Poorly-differentiated | 43 (50.0) | Grade III | 50 (45.9) |
| Lauren classification | Relapse | ||
| Intestinal type | 93 (85.3) | Present | 31 (28.4) |
| Diffuse type | 16 (14.7) | Recurrent pattern | 21 (75.0) |
| Distant metastasis |